35 business days, excluding weekends and holidays

NAD+ Cycle Length Planning Examples Planning framework 4-week SubQ planning Loading or maintenance context Assessment or titration phase Review or adjustment point Review at week 4 Evidence type Community and clinic planning Planning framework 8-week SubQ planning Loading or maintenance context Titration followed by a regular planning phase Review or adjustment point Review at weeks 4 and 8 Evidence type Community and clinic planning Planning framework 12-week SubQ planning Loading or maintenance context Titration followed by maintenance planning Review or adjustment point Review every 4 weeks Evidence type Community and clinic planning Planning framework IV loading plus maintenance Loading or maintenance context 3-5 daily sessions, then weekly or monthly Review or adjustment point Review after loading and every 4-8 weeks Evidence type Supervised clinic practice Planning framework Continuous or ongoing planning Loading or maintenance context Frequency may be adjusted instead of using a fixed break Review or adjustment point Review every 4-8 weeks Evidence type Clinic and community planning NAD+ does not have to be cycled on and off

Common symptoms involve brain fog, issues with focus, memory lapses, depression, or mood fluctuations
i RESEARCH USE ONLY This product is not intended for diagnostic, therapeutic, or human use
Good product
Research Applications Comprehensive musculoskeletal repair research Tendon and ligament regeneration studies Wound healing and skin repair models Inflammation modulation research Synergistic dual-peptide mechanism studies Quality Specifications Purity: 98% (HPLC verified) Compound: BPC-157 + TB-500 Molecular Weight: 1419.5 Da / 2113.4 Da Form: Lyophilized powder Origin: Made in the USA Testing: Third-party tested in a US laboratory Storage: -20C, protect from light COA: Batch-specific, ISO-accredited laboratory Frequently Asked Questions Q: Why combine BPC-157 and TB-500